Adaptive Biotechnologies President, COO Julie Rubinstein disposes of $830,400 in common shares
ADPT•Adaptive Biotechnologies President and COO Julie Rubinstein sold 35,643 shares for a reported $830,400 across transactions on Oct. 9, 12 and 13. Her holdings fell to 377,802 shares after the trades.
1. Share sales
Rubinstein sold 35,643 shares at prices of $26.41, $25.35, $26.07 and $25.50. The trades followed option exercises of 11,881 shares at $12.14 on each date.
